...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Expectations for the AGM?
Reply New Message
Prev Message Back To Forum Threaded View Next Message

It has always intrigued me as to if Zcc is sold how does that impact the ability to sell RVX?The Royalty shares in my opinion would have to be excluded to make RVX saleable.Unles of course it would be the same buyer.I do believe that Zen Wil go first.

Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply